4//SEC Filing
OELKE MATHIAS 4
Accession 0001209191-22-058800
CIK 0001538210other
Filed
Nov 24, 7:00 PM ET
Accepted
Nov 25, 5:04 PM ET
Size
8.3 KB
Accession
0001209191-22-058800
Insider Transaction Report
Form 4
NexImmune, Inc.NEXI
OELKE MATHIAS
Chief Science Officer
Transactions
- Award
Common Stock
2022-11-22+126,100→ 134,023 total
Footnotes (2)
- [F1]Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest 100% on the 18-month anniversary of the grant date, subject to Mr. Oelke's continued service through the applicable vesting date.
- [F2]Excludes 223,634 shares of common stock underlying options that are currently exercisable.
Documents
Issuer
NexImmune, Inc.
CIK 0001538210
Entity typeother
Related Parties
1- filerCIK 0001921607
Filing Metadata
- Form type
- 4
- Filed
- Nov 24, 7:00 PM ET
- Accepted
- Nov 25, 5:04 PM ET
- Size
- 8.3 KB